Luc Daigneault

446 total citations
21 papers, 357 citations indexed

About

Luc Daigneault is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Luc Daigneault has authored 21 papers receiving a total of 357 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Cancer Research and 7 papers in Molecular Biology. Recurrent topics in Luc Daigneault's work include interferon and immune responses (6 papers), Prostate Cancer Treatment and Research (6 papers) and Virus-based gene therapy research (3 papers). Luc Daigneault is often cited by papers focused on interferon and immune responses (6 papers), Prostate Cancer Treatment and Research (6 papers) and Virus-based gene therapy research (3 papers). Luc Daigneault collaborates with scholars based in Canada and United Kingdom. Luc Daigneault's co-authors include Hélène Dulude, Chandra J. Panchal, Daniel Skup, Jonathan R. Reeves, Benoit Coulombe, Dharam Ramnani, Bryan Williams, Seema V. Garde, Marjan Emami and Jinzi J. Wu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Luc Daigneault

21 papers receiving 340 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luc Daigneault Canada 11 169 113 112 87 65 21 357
Kristiann M. Dougherty United States 8 179 1.1× 60 0.5× 130 1.2× 69 0.8× 36 0.6× 9 353
Maryann Mikhail United States 9 158 0.9× 102 0.9× 140 1.3× 94 1.1× 52 0.8× 16 365
Takanori Nishimori Japan 12 308 1.8× 54 0.5× 123 1.1× 71 0.8× 82 1.3× 30 490
Shui Hao China 13 249 1.5× 71 0.6× 154 1.4× 65 0.7× 40 0.6× 45 566
Jonathan G. Bijron United States 8 235 1.4× 66 0.6× 164 1.5× 141 1.6× 72 1.1× 13 667
Elisabeth Emilsen Norway 10 280 1.7× 60 0.5× 167 1.5× 80 0.9× 60 0.9× 17 428
Jorg Michels Canada 8 280 1.7× 91 0.8× 151 1.3× 71 0.8× 85 1.3× 14 451
Penny Johnson United Kingdom 9 145 0.9× 77 0.7× 148 1.3× 69 0.8× 48 0.7× 9 349
Mustafa A. Barbhuiya India 11 244 1.4× 67 0.6× 106 0.9× 76 0.9× 46 0.7× 19 424
Huiyin Lee Singapore 8 213 1.3× 61 0.5× 91 0.8× 104 1.2× 142 2.2× 9 438

Countries citing papers authored by Luc Daigneault

Since Specialization
Citations

This map shows the geographic impact of Luc Daigneault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luc Daigneault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luc Daigneault more than expected).

Fields of papers citing papers by Luc Daigneault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luc Daigneault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luc Daigneault. The network helps show where Luc Daigneault may publish in the future.

Co-authorship network of co-authors of Luc Daigneault

This figure shows the co-authorship network connecting the top 25 collaborators of Luc Daigneault. A scholar is included among the top collaborators of Luc Daigneault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luc Daigneault. Luc Daigneault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tehfé, Mustapha, Marie Florescu, Denis Soulières, et al.. (2015). Phase I and II studies of the decitabine–genistein drug combination in advanced solid tumors.. Journal of Clinical Oncology. 33(15_suppl). e13556–e13556. 7 indexed citations
2.
Annabi, Borhane, Jean-Christophe Currie, Hélène Dulude, et al.. (2006). Contribution of the 37-kDa laminin receptor precursor in the anti-metastatic PSP94-derived peptide PCK3145 cell surface binding. Biochemical and Biophysical Research Communications. 346(1). 358–366. 13 indexed citations
3.
Annabi, Borhane, Jean-Christophe Currie, Hélène Dulude, et al.. (2006). Inhibition of MMP-9 secretion by the anti-metastatic PSP94-derived peptide PCK3145 requires cell surface laminin receptor signaling. Anti-Cancer Drugs. 17(4). 429–438. 15 indexed citations
4.
Reeves, Jonathan R., Hélène Dulude, Chandra J. Panchal, Luc Daigneault, & Dharam Ramnani. (2006). Prognostic Value of Prostate Secretory Protein of 94 Amino Acids and its Binding Protein after Radical Prostatectomy. Clinical Cancer Research. 12(20). 6018–6022. 60 indexed citations
5.
Nam, Robert K., Jonathan R. Reeves, Ants Toi, et al.. (2006). A Novel Serum Marker, Total Prostate Secretory Protein of 94 Amino Acids, Improves Prostate Cancer Detection and Helps Identify High Grade Cancers at Diagnosis. The Journal of Urology. 175(4). 1291–1297. 56 indexed citations
6.
Hawkins, Robert E., Luc Daigneault, Richard Cowan, et al.. (2005). Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer. PubMed. 4(2). 91–99. 12 indexed citations
7.
Annabi, Borhane, Jean-Christophe Currie, Robert D. Hawkins, et al.. (2005). A PSP94-derived Peptide PCK3145 inhibits MMP-9 Secretion and Triggers CD44 Cell Surface Shedding: Implication in Tumor Metastasis. Clinical & Experimental Metastasis. 22(5). 429–439. 33 indexed citations
8.
Daigneault, Luc, C. Panchal, Howard I. Scher, et al.. (2005). A synthetic peptide, PCK3145, for the treatment of hormone refractory prostate cancer. Journal of Clinical Oncology. 23(16_suppl). 4654–4654. 1 indexed citations
9.
Hawkins, Robert D., C. Panchal, Hélène Dulude, et al.. (2004). A multiple ascending dose, open-label, phase IIa study evaluating the safety and tolerability of PCK3145 administered intravenously in patients with metastatic hormone refractory prostate cancer (HRPC). Journal of Clinical Oncology. 22(14_suppl). 4636–4636. 2 indexed citations
10.
Daigneault, Luc, Hélène Dulude, C. Panchal, et al.. (2004). Evaluation of biological activity of PCK3145 in metastatic hormone resistant prostatic cancer (HRPC) using serum markers. Journal of Clinical Oncology. 22(14_suppl). 4692–4692. 2 indexed citations
11.
Gelmon, Karen A., Jean Latreille, Anthony W. Tolcher, et al.. (2000). Phase I Dose-Finding Study of a New Taxane, RPR 109881A, Administered as a One-Hour Intravenous Infusion Days 1 and 8 to Patients With Advanced Solid Tumors. Journal of Clinical Oncology. 18(24). 4098–4108. 46 indexed citations
12.
Burns, Robert J., Sian Iles, Anthony Fung, Linda M. Wright, & Luc Daigneault. (1995). The Canadian exercise technetium 99m-labeled teboroxime single-photon emission computed tomographic study. Journal of Nuclear Cardiology. 2(2). 117–125. 1 indexed citations
13.
Daigneault, Luc, et al.. (1995). Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines. Clinical & Experimental Metastasis. 13(5). 7 indexed citations
14.
Daigneault, Luc, et al.. (1992). Two distinct pathways of interferon induction as revealed by 2-aminopurine. Nucleic Acids Research. 20(11). 2749–2754. 7 indexed citations
15.
Daigneault, Luc & Daniel Skup. (1992). Increased levels of interferon regulatory element-binding activities in nuclei of high interferon-producing If-1h mice.. PubMed. 3(2). 93–100. 4 indexed citations
16.
Cohen, Lucie, Judith Lacoste, Michael A. Parniak, et al.. (1991). Stimulation of interferon beta gene transcription in vitro by purified NF-kappa B and a novel TH protein.. PubMed. 2(7). 323–33. 10 indexed citations
17.
Lacoste, Judith, Michael A. Parniak, Luc Daigneault, Daniel Skup, & John Hiscott. (1991). Stimulation of Interferon $ Gene Transcrition in Vitro by Purified NF-icB and a Novel TH Protein. 3 indexed citations
18.
André, Patrice, et al.. (1988). An embryonic DNA-binding protein specific for a region of the human IFN 1, promoter. Nucleic Acids Research. 16(22). 10575–10592. 11 indexed citations
19.
Coulombe, Benoit, et al.. (1988). Presence of Transcription Regulatory Elements within an Intron of the Virus-Inducible Murine TIMP Gene. Molecular and Cellular Biology. 8(8). 3227–3234. 15 indexed citations
20.
Daigneault, Luc, Benoit Coulombe, & Daniel Skup. (1988). Regulation of interferon gene expression: mechanism of action of the If-1 locus. Journal of Virology. 62(4). 1125–1131. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kristiann M. Dougherty Breakdown of academic impact, for papers by Maryann Mikhail Breakdown of academic impact, for papers by Takanori Nishimori Breakdown of academic impact, for papers by Shui Hao Breakdown of academic impact, for papers by Jonathan G. Bijron Breakdown of academic impact, for papers by Elisabeth Emilsen Breakdown of academic impact, for papers by Jorg Michels Breakdown of academic impact, for papers by Penny Johnson Breakdown of academic impact, for papers by Mustafa A. Barbhuiya Breakdown of academic impact, for papers by Huiyin Lee
Rankless by CCL
2026